» Articles » PMID: 38973915

Identification of a Cryptic Pocket in Methionine Aminopeptidase-II Using Adaptive Bandit Molecular Dynamics Simulations and Markov State Models

Overview
Journal ACS Omega
Specialty Chemistry
Date 2024 Jul 8
PMID 38973915
Authors
Affiliations
Soon will be listed here.
Abstract

Methionine aminopeptidase-II (MetAP-II) is a metalloprotease, primarily responsible for the cotranslational removal of the N-terminal initiator methionine from the nascent polypeptide chain during protein synthesis. MetAP-II has been implicated in angiogenesis and endothelial cell proliferation and is therefore considered a validated target for cancer therapeutics. However, there is no effective drug available against MetAP-II. In this study, we employ Adaptive Bandit molecular dynamics simulations to investigate the structural dynamics of the apo and ligand-bound MetAP-II. Our results focus on the dynamic behavior of the disordered loop that is not resolved in most of the crystal structures. Further analysis of the conformational flexibility of the disordered loop reveals a hidden cryptic pocket that is predicted to be potentially druggable. The network analysis indicates that the disordered loop region has a direct signaling route to the active site. These findings highlight a new way to target MetAP-II by designing inhibitors for the allosteric site within this disordered loop region.

References
1.
Michaud-Agrawal N, Denning E, Woolf T, Beckstein O . MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J Comput Chem. 2011; 32(10):2319-27. PMC: 3144279. DOI: 10.1002/jcc.21787. View

2.
Kozakov D, Grove L, Hall D, Bohnuud T, Mottarella S, Luo L . The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins. Nat Protoc. 2015; 10(5):733-55. PMC: 4762777. DOI: 10.1038/nprot.2015.043. View

3.
Carducci M, Wang D, Habermehl C, Bodding M, Rohdich F, Lignet F . A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors. Cancer Res Commun. 2023; 3(8):1638-1647. PMC: 10448909. DOI: 10.1158/2767-9764.CRC-23-0048. View

4.
Klein C, Schiffmann R, Folkers G, Piana S, Rothlisberger U . Protonation states of methionine aminopeptidase and their relevance for inhibitor binding and catalytic activity. J Biol Chem. 2003; 278(48):47862-7. DOI: 10.1074/jbc.M305325200. View

5.
Hu X, Addlagatta A, Lu J, Matthews B, Liu J . Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression. Proc Natl Acad Sci U S A. 2006; 103(48):18148-53. PMC: 1838721. DOI: 10.1073/pnas.0608389103. View